In an unprecedented move, biopharmaceutical company Hoth Therapeutics announced on Wednesday that it plans to buy $1M worth of BTC, sparking market discussions globally. The company’s Board of Directors approved the abovementioned purchase, primarily in an effort to strengthen the firm’s treasury reserve. This announcement has further gained significant traction as the flagship crypto continues to witness soaring institutional interest post-U.S. elections.
Just-in: Hoth Therapeutics Board Approves $1M Bitcoin Buying Plan
coingape.com
20 November 2024 17:20, UTC